TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: Cavalcanti et al. stated that 12 out of 41 (29.2%) CML patients overexpressed p53 protein (mostly seen in the AP and BC of the disease), accompanied by multidrug resistance (MDR) function [405].